Pcn349 - Can We Apply the Utility Prediction Mathematical Model for Recurrent Metastatic Breast Cancer to Japanese Patients?

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.431
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Developing a Prediction Model for Benefit From Fulvestrant in Heavily Pretreated Metastatic Breast Cancer Patients

Breast Cancer Research
Cancer ResearchOncology
2009English

Can We Prevent Breast Cancer?*

British Journal of Cancer
Cancer ResearchOncology
1991English

Feasibility Study of Personalized Peptide Vaccination for Metastatic Recurrent Triple-Negative Breast Cancer Patients

Breast Cancer Research
Cancer ResearchOncology
2014English

Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer

Frontiers in Oncology
Cancer ResearchOncology
2020English

Prediction of Metastatic Damage of Regional Lymphatic Nodes in Patients With Breast Cancer

Tumors of female reproductive system
2017English

To Cut Is to Cure: Can We Really Apply Z11 in Practice?

Annals of Surgical Oncology
OncologySurgery
2011English

Monitoring and Caring for Breast Cancer Patients With Post-Treatment Problems: What Can We Do?

Breast Cancer Management
OncologyRadiologyNuclear MedicineImaging
2012English

Vascular Senescense and Endothelial Function ― Can We Apply It to Atrial Fibrillation? ―

Circulation Journal
MedicineCardiovascular MedicineCardiology
2019English

Trastuzumab Resistance: What Are We Offering to Breast Cancer Patients?

Journal of Clinical & Experimental Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy